Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.41% |
| 2 | Technology | 7.27% |
| 3 | Financials | 6.46% |
| 4 | Consumer Discretionary | 5.3% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VNE
1326
DELISTED
Veoneer, Inc.
VNE
| $4.82M | 0.01% |
659,034
+134,976
| +26% | +$1.61M |
|
1327
California Water Service
CWT
$3.1B
| $4.82M | 0.01% |
95,854
+36,291
| +61% | +$1.88M |
|
1328
VeriSign
VRSN
$26.2B
| $4.82M | 0.01% |
26,764
-114,236
| -81% | -$22.5M |
|
1329
Keurig Dr Pepper
KDP
$42.3B
| $4.81M | 0.01% |
198,230
-153,545
| -44% | -$4.14M |
|
|
EVRI
1330
DELISTED
Everi Holdings
EVRI
| $4.81M | 0.01% |
1,457,331
-387,661
| -21% | -$3.95M |
|
1331
Pentair
PNR
$10.4B
| $4.8M | 0.01% |
161,412
+18,384
| +13% | +$739K |
|
|
RARX
1332
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $4.8M | 0.01% |
100,043
-521,123
| -84% | -$24.2M |
|
|
MRO
1333
DELISTED
Marathon Oil Corporation
MRO
| $4.8M | 0.01% |
1,459,387
+1,267,985
| +662% | +$11.7M |
|
1334
Gyre Therapeutics
GYRE
$641M
| $4.8M | 0.01% |
146,378
+50,729
| +53% | +$2.33M |
|
1335
Opko Health
OPK
$985M
| $4.79M | 0.01% |
3,571,399
+2,676,774
| +299% | +$4.19M |
|
1336
Kura Oncology
KURA
$800M
| $4.78M | 0.01% |
480,718
-149,009
| -24% | -$1.71M |
|
|
PRNB
1337
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $4.78M | 0.01% |
+80,484
| New | +$4.69M |
|
1338
CALL
Lam Research
LRCX
$367B
| $4.78M | 0.01% |
199,000
-41,000
| -17% | -$1.18M |
|
|
CCH.WS
1339
CALL
DELISTED
Collier Creek Holdings Warrants, each whole warrant exercisable for one Class A ordinary share at an
CCH.WS
| $4.77M | 0.01% |
+466,666
| New | +$793K |
|
1340
Shopify
SHOP
$152B
| $4.77M | 0.01% |
114,350
+107,160
| +1,490% | +$4.83M |
|
1341
BlackLine
BL
$1.84B
| $4.77M | 0.01% |
90,616
-449,344
| -83% | -$26.3M |
|
|
APTO
1342
DELISTED
Aptose Biosciences, Inc.
APTO
| $4.77M | 0.01% |
1,783
-62
| -3% | -$185K |
|
|
CUK
1343
DELISTED
Carnival PLC
CUK
| $4.76M | 0.01% |
398,664
+149,349
| +60% | +$5M |
|
1344
Zillow
Z
$7.79B
| $4.74M | 0.01% |
131,657
+124,374
| +1,708% | +$5.74M |
|
1345
Gilead Sciences
GILD
$162B
| $4.74M | 0.01% |
63,410
-1,251,286
| -95% | -$86.5M |
|
1346
Iovance Biotherapeutics
IOVA
$1.82B
| $4.73M | 0.01% |
+157,930
| New | +$4.19M |
|
1347
Fluor
FLR
$7.01B
| $4.72M | 0.01% |
683,817
-1,212,507
| -64% | -$16.9M |
|
1348
CALL
iShares MSCI Brazil ETF
EWZ
$9.28B
| $4.71M | 0.01% |
200,000
| – | – |
|
1349
SM Energy
SM
$7.8B
| $4.71M | 0.01% |
3,858,571
+3,104,684
| +412% | +$22M |
|
1350
Hecla Mining
HL
$9.47B
| $4.7M | 0.01% |
2,581,848
-1,113,055
| -30% | -$3.08M |
|
Similar funds
Millennium Management's Q1 2020 Portfolio in Review
As of Q1 2020, Millennium Management held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Danaher worth $133M.
- Millennium Management's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Millennium Management added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Millennium Management's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Millennium Management fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Millennium Management opened 789 new positions and closed 1,154 in Q1 2020.
- Millennium Management's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.